Diagnostics Dialogues - Innovation & Insight
Health & Fitness
The number of Americans living with Alzheimer's Disease (AD) continues to grow at an exponential rate. Currently, more than 6 million Americans have AD, and that number is expected to double by 2050. But recent research findings are beginning to show the important role diagnostics may play in the next era of AD. New diagnostic innovations could unleash a future of effective therapies, treatments, and improved outcomes for patients who suffer from this disease.
In this episode, host Dr Pat Alagia, Senior Medical Director for Women’s and Reproductive Health at Quest Diagnostics, welcomes Dr Michael K. Racke to discuss:
About our guests
Dr Michael K. Racke is Medical Director for Neurology at Quest Diagnostics. He is a leader in the field of neurology and neuroimmunology with special expertise in multiple sclerosis.
After receiving his Doctor of Medicine from the University of Medicine and Dentistry of New Jersey, Dr Racke completed a medical internship and neurology residency at Emory University School of Medicine, followed by a neuroimmunology fellowship at the National Institute of Neurological Disorders and Stroke (NINDS) and the National Institutes of Health (NIH).
Dr Racke’s research focuses on developing novel tests for neurologic disorders, including monitoring therapeutic responses in diseases such as multiple sclerosis. He has authored more than 200 peer-reviewed papers, book chapters, and reviews on the pathogenesis of neuroimmunology diseases. He has over 3 decades of leadership experience in academia and clinical practice and continues to serve on several national professional society committees.
Dr Racke is board certified by the American Board of Psychiatry and Neurology and is a member of the American Academy of Neurology and American Association of Immunologists.
------------------------------
Quest Diagnostics empowers people to take action to improve health outcomes. Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors, and improve healthcare management. Quest Diagnostics annually serves 1 in 3 adult Americans and half the physicians and hospitals in the United States, and our 47,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives.
More information is available at www.QuestDiagnostics.com
A Commitment To Women’s Health
Growing as a Laboratory Partner
Commitment to Employee Health: A Blueprint for Wellness
Exploring Digital Pathology and Artificial Intelligence
Disease Surveillance: Preventing the Next Pandemic
Welcome to Season 2 of Diagnostic Dialogues - Innovation & Insight
The successful convergence of clinical and operational thinking in the lab
Achieving the Triple Aim through the power of strong laboratory partnerships
The view from the top: Looking back and ahead in 2022
The power of laboratory analytics
Trends in drug testing resulting from the COVID-19 pandemic
Patient-minded Neurology
Optimize Oncology Care with Clinical Pathways
COVID-19: Supporting Safety for the Front Line
About Diagnostics Dialogues from Quest Diagnostics
Create your
podcast in
minutes
It is Free
The Relaxback UK Show
Your Sleep Guru Podcast
Good Nurse Bad Nurse
Nothing much happens: bedtime stories to help you sleep
Huberman Lab